BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24800782)

  • 21. [Timing of surgery after neoadjuvant chemotherapy for advanced gastric cancer].
    Hu X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jun; 16(6):509-12. PubMed ID: 23801199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pilot feasibility study of neoadjuvant chemoradiotherapy with S-1 in patients with locally advanced gastric cancer featuring adjacent tissue invasion or JGCA bulky N2 lymph node metastases.
    Inoue T; Yachida S; Usuki H; Kimura T; Hagiike M; Okano K; Suzuki Y
    Ann Surg Oncol; 2012 Sep; 19(9):2937-45. PubMed ID: 22466666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoadjuvant chemotherapy with FOLFOX: improved outcomes in Chinese patients with locally advanced gastric cancer.
    Li ZY; Koh CE; Bu ZD; Wu AW; Zhang LH; Wu XJ; Wu Q; Zong XL; Ren H; Tang L; Zhang XP; Li JY; Hu Y; Shen L; Ji JF
    J Surg Oncol; 2012 Jun; 105(8):793-9. PubMed ID: 22189752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy.
    Ott K; Rachakonda PS; Panzram B; Keller G; Lordick F; Becker K; Langer R; Buechler M; Hemminki K; Kumar R
    Ann Surg Oncol; 2011 Sep; 18(9):2688-98. PubMed ID: 21347786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer.
    Barone C; Cassano A; Pozzo C; D'Ugo D; Schinzari G; Persiani R; Basso M; Brunetti IM; Longo R; Picciocchi A
    Oncology; 2004; 67(1):48-53. PubMed ID: 15459495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review and meta-analysis.
    Gosavi R; Chia C; Michael M; Heriot AG; Warrier SK; Kong JC
    Int J Colorectal Dis; 2021 Oct; 36(10):2063-2070. PubMed ID: 33945007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neoadjuvant chemotherapy for patients with positive cytology from advanced gastric cancer].
    Nakagawa S; Nashimoto A; Yabusaki H
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1774-6. PubMed ID: 17212104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neoadjuvant chemotherapy for locally advanced gastric cancer].
    Kalmár K; Cseke L; Káposztás Z; Horváth G; Varga E
    Magy Seb; 2003 Oct; 56(5):177-84. PubMed ID: 15022621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Meta-analysis of adjuvant chemotherapy on prognosis for gastric cancer patients after D2 dissection].
    Xia GG; Zhang CH; Wei ZW; Wu Y; He YL
    Zhonghua Wai Ke Za Zhi; 2013 May; 51(5):447-51. PubMed ID: 23958170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Outcome of Doublet and Triplet Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer.
    Kim JS; Kang SH; Moon HS; Sung JK; Jeong HY; Sul JY
    Korean J Gastroenterol; 2016 Nov; 68(5):245-252. PubMed ID: 27871160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination.
    Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Okada K; Mori M; Doki Y
    Ann Surg Oncol; 2011 Dec; 18(13):3726-31. PubMed ID: 21584835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.
    Inoue K; Nakane Y; Kogire M; Fujitani K; Kimura Y; Imamura H; Tamura S; Okano S; Kwon AH; Kurokawa Y; Shimokawa T; Takiuchi H; Tsujinaka T; Furukawa H
    Eur J Surg Oncol; 2012 Feb; 38(2):143-9. PubMed ID: 22154885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Multimodal therapy in locally advanced gastric cancer].
    Bölke E; Peiper M; Knoefel WT; Baldus SE; Schauer M; Matuschek C; Gerber PA; Hoff NP; Budach W; Gattermann N; Erhardt A; Scherer A; Buhren BA; Orth K
    Dtsch Med Wochenschr; 2011 Oct; 136(43):2205-11. PubMed ID: 22009175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
    Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
    Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of neoadjuvant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer: an international collaborative meta-analysis.
    Kim HS; Sardi JE; Katsumata N; Ryu HS; Nam JH; Chung HH; Park NH; Song YS; Behtash N; Kamura T; Cai HB; Kim JW
    Eur J Surg Oncol; 2013 Feb; 39(2):115-24. PubMed ID: 23084091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemoradiation therapy versus chemotherapy alone for gastric cancer after R0 surgical resection: a meta-analysis of randomized trials.
    Min C; Bangalore S; Jhawar S; Guo Y; Nicholson J; Formenti SC; Leichman LP; Du KL
    Oncology; 2014; 86(2):79-85. PubMed ID: 24435019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
    Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant chemotherapy in advanced gastric and esophago-gastric cancer. Meta-analysis of randomized trials.
    Coccolini F; Nardi M; Montori G; Ceresoli M; Celotti A; Cascinu S; Fugazzola P; Tomasoni M; Glehen O; Catena F; Yonemura Y; Ansaloni L
    Int J Surg; 2018 Mar; 51():120-127. PubMed ID: 29413875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of target combined chemotherapy in advanced gastric cancer: a meta-analysis and system review.
    Zou K; Yang S; Zheng L; Yang C; Xiong B
    BMC Cancer; 2016 Sep; 16(1):737. PubMed ID: 27633381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.